HAFT NICHOLAS purchased 1.6% of their position (63.85K shares) of FINCH THERAPEUTICS GROUP, INC. on the open market
Open‑market purchase worth $650.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2021ACC: 0001567619-21-022453
Director
Since Mar 2021
+63.85K
Net shares
Net buyer
$650.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
63.85K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value per share
Indirect
Shares
+63.85K
Price / share
$10.18
Trade value
$649.99K
% of position
1.6%
12/20/2021
3.99M→4.06M
Total
Net shares
+63.85K
Net value
$649.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share Indirect | 12/20/2021 | P · Purchase | +63.85K | $10.18 | $649.99K | 1.6% | 3.99M | 4.06M |
| Total | +63.85K | $649.99K | ||||||
Derivative Transactions0
No derivative transactions reported